Home/ Stocks/ ENVB

Enveric Biosciences, Inc. Common Stock

ENVB XNAS

$1.95 -0.12 (-5.97%) ▼ 15-min delayed

Open

$1.99

High

$1.99

Low

$1.95

Volume

7.9K

Market Cap

$2.78M

About Enveric Biosciences, Inc. Common Stock

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 6 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$274	$-1,873,669	$-10.81
Q2 2025	$-132	$-2,519,181	$-0.97
Q1 2025	$2	$-2,184,966	$-1.22
FY 2024	$219	$-9,574,987	$-19.04

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

Related Market News

No specific coverage for ENVB yet. Check out our latest market news or earnings calendar.

Get ENVB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Enveric Biosciences, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.